Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes. (2018)
Attributed to:
Tackling autophagy and apoptosis for the potential therapy of Huntington's Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/brain/awy081
PubMed Identifier: 29608652
Publication URI: http://europepmc.org/abstract/MED/29608652
Type: Journal Article/Review
Volume: 141
Parent Publication: Brain : a journal of neurology
Issue: 6
ISSN: 0006-8950